REBEL EM is licensed under a
© 2022 REBEL EM. All rights reserved. | Disclaimer | Website by Innov8 Place.
Archive
Medical Category: Neurology
The ESETT Trial: 2nd Line Medications in Status Epilepticus
Background: Dealing with a patient in status epilepticus, refractory to treatment with benzodiazepines, can be a sphincter tightening ordeal. While most seizure activity responds to appropriately dosed benzodiazipines, some will not respond. The choice of second line medication has been …
REBEL Core Cast 24.0 – Stroke Update 2019
Take Home Points Important as front line providers to know research and data behind stroke care Patients eligible for endovascular care are those with large vessel occlusion in the anterior circulation – anterior cerebral artery, middle cerebral artery, distal intracranial …
REBEL Cast Ep72: Systemic Alteplase in Stroke Mimics is Safe?
Background: Currently, alteplase is the mainstay of treatment of acute ischemic stroke. Advocates of alteplase suggest that the benefit of alteplase is greatest when given early and declines with increasing time from stroke symptom onset (i.e. time is brain). Therefore, the …